Eurartesim, the first artemisinin combination therapy (ACT) approved in Europe to treat uncomplicated malaria, is being prepared for launch in …
Our round-up of news in the pharmaceutical manufacturing arena covers developments at Genzyme, Enzon/Sigma-Tau, Catalent, Synco Bio Partners, Angel Biotech, …

